institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

FDA approves gene therapy skin grafts for epidermolysis bullosa

A Stanford-led phase 3 trial shows gene therapy skin grafts significantly heal chronic wounds in patients with severe epidermolysis bullosa, reducing pain and improving quality of life Epidermolysis bullosa is the name for a group of rare inherited skin disorders that cause the skin to become very fragile; even the slightest touch can cause blistering. The condition is usually diagnosed in babies and young children, as symptoms can be evident fr…
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Open Access Government broke the news in on Thursday, June 26, 2025.
Sources are mostly out of (0)

You have read 1 out of your 5 free daily articles.